Real-world adoption of bevacizumab-bvzr biosimilar was retrospectively assessed, revealing switching between biosimilars and the reference product and utilization in extrapolated indications and combination regimens.
Jose Maria Jimenez Alvir, DrPH
Advertisement
Articles by Jose Maria Jimenez Alvir, DrPH
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
5 FAQs: Ebola Outbreaks and the Challenge of Public Trust
2
How Hospital Specialty Pharmacies Are Closing the Pharmacy Desert Gap
3
Targeting Oxidative Stress Could Fill a Gap in the Vitiligo Treatment Toolbox
4
How Healthy Gut Microbiota Can Give CAR T-Cell Recipients a Leg Up
5